hemi-ventures

$4.3Tdisclosed portfolio round capital

10 Oct, 2018last investment

1portfolio companies

0team members

Analyst signals

Portfolio activity and matriculation

Metrics use all recorded activity through 21 Jul 2026 across series a. Later-round outcomes are capped at the period end.

100%companies with a later round · 1/1

1000000.00×median round-size step-up · n=1

Not availablemedian valuation step-up · n=0

0%recorded-solo rate · 0 solo / 2 syndicated

Healthcare · 1 companies

These are activity signals, not fund-return metrics. Round capital is the full disclosed financing amount, not this fund's check size. “Recorded solo” means only one investor is present in the source data and is a lead signal, not verified lead status; syndicated rounds are a co-investor or follower signal. IRR, TVPI, DPI, ownership, exits, and market beta cannot be calculated from the available records.

People

Team

No team details are available yet.

Portfolio

Investments

Full financing histories for portfolio companies. Highlighted rounds are those where hemi-ventures is recorded as an investor.

Nebula Genomics

out of scope

Healthcare

Nebula Genomics is a personal genomics company that provides advanced DNA testing through 30x Whole Genome Sequencing, decoding 100% of a user's DNA. Founded by Harvard and MIT Professor George Church, the company analyzes saliva samples to offer insights into health, ancestry, and genetic traits. Nebula Genomics prioritizes user privacy and control over their data, while also offering opportunities to participate in scientific research. Their services, which are intended for research, informational, and educational use, are also available through DNA Complete.

Series A10 Oct, 2018$4.3T roundSyndicated · 12 disclosed investors

Series A1 Aug, 2018$4.3M roundSyndicated · 10 disclosed investors